TrialBMC clinical pharmacology2011

No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study.

Christian de Mey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.